CVOTs cardiovascular outcome trials, T2DM type 2 diabetes mellitus, GLP-1RAs GLP-1 receptor agonists, HbA1c glycated hemoglobin, ACS acute coronary syndrome, OAD oral antidiabetic drugs, eGFR estimated glomerular filtration rate, UACR urine albumin-creatinine ratio, CVD cardiovascular disease, BMI body mass index, T1DM type 1 diabetes mellitus, DPP-4i DPP-4 inhibitor, HR hazard ratio, CI confidence interval, HF heart failure Outside of those major clinical trials, a nationwide retrospective study in Taiwan, China, evaluated the effects of DPP-4i in elderly patients with T2DM relative to cardiovascular outcomes
Appl Sci 13(6):3448 van Dorst JM, Tam RY, Ooi CY (2022) What do we know about the microbiome in cystic fibrosis
Clarkson has not publicly discussed the financial aspect of her treatment
Key Features: Brand: Niramay Medico
doi: 10.1249/mss.0b013e3180383da5
FOX 9 has extensively reported on pharmacy benefit managers as the companies faced a review by the FTC, while looking at the impact they've had on small pharmacies
